N-[2-4-(1H-Imidazol-1-yl)alkyl]-arylamides and pharmaceutical
申请人:American Cyanamid Company
公开号:US04568687A1
公开(公告)日:1986-02-04
This disclosure describes novel N-[.omega.-(1H-imidazol-1-yl)alkyl]arylamides which possess the property of inhibiting the enzyme thromboxane synthetase and are also useful in the treatment of hypertension and myocardial ischemia.
This disclosure describes novel N-[ω-(1H-imidazol-1-yl)alkyl]arylamides which possess the property of inhibiting the enzyme thromboxane synthetase and are also useful in the treatment of hypertension and myocardial ischemia.